Hector R Mendez-gomez

Title: Hector R. Mendez-Gomez: Advancing Hydrogel-Based Immunotherapy

Introduction

Hector R. Mendez-Gomez is an inventor associated with Gainesville, Florida, and the University of Florida Research Foundation, Inc. His work includes an invention focused on biocompatible nanocomposite hydrogels for immunotherapy vaccines. He is credited with 1 patent.

Latest Patents

Mendez-Gomez’s patent, “Biocompatible Nanocomposite Hydrogel Immunotherapy Vaccines and Methods of Use Thereof,” describes vaccine compositions that combine a biocompatible hydrogel material, immune-stimulating cytokines such as CXCL9, and nanoliposomes loaded with mRNA molecules corresponding to a target antigen.

The disclosure also covers methods for preparing these compositions and using the vaccines to treat or prevent disease. By bringing together immune-stimulating components and antigen-encoding mRNA, the invention presents a platform for developing targeted vaccine approaches.

Career Highlights

A key highlight of Mendez-Gomez’s patent work is its focus on integrating hydrogel materials with cytokines and mRNA-loaded nanoliposomes. The invention addresses both vaccine composition and potential methods of use, connecting materials design with therapeutic applications.

Collaborations

Mendez-Gomez’s listed coworkers include Farhad Dastmalchi and Maryam Rahman. His patent is associated with the University of Florida Research Foundation, Inc.

Conclusion

Hector R. Mendez-Gomez’s patented work explores a nanocomposite hydrogel platform for immunotherapy vaccines, combining biomaterials, immune-stimulating cytokines, and mRNA delivery in an approach intended to support disease treatment or prevention.